Moreover, the delivery of exogenous CXCL10 boosts the number and function of HSV-1 specific CD8+ T cells and improves the protection against recurrent herpesvirus infection and disease in mice [29]. The gene discussed is CD8A; the disease is Herpesviridae infectious disease.